NCT07517081

Brief Summary

Deep infiltrating endometriosis (DIE) involving the bowel, particularly the rectosigmoid region, is associated with significant gastrointestinal symptoms and impaired quality of life. Rectal shaving is a conservative surgical technique aimed at removing endometriotic lesions while preserving bowel integrity; however, it may result in residual disease or excessive thinning of the bowel wall, potentially leading to recurrence or complications. Intraoperative ultrasound (IOUS) allows real-time assessment of residual nodule thickness and bowel wall thickness after shaving. This prospective observational study aims to evaluate the relationship between intraoperative ultrasound measurements and postoperative clinical outcomes, including gastrointestinal symptoms and quality of life. The study also seeks to identify ultrasound cut-off values that may guide intraoperative surgical decision-making and optimize the balance between radicality and safety.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for all trials

Timeline
23mo left

Started Apr 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Apr 2026Jul 2028

First Submitted

Initial submission to the registry

April 1, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

April 7, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2027

Expected
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2028

Last Updated

April 8, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

April 1, 2026

Last Update Submit

April 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Gastrointestinal Symptoms and Quality of Life Scores

    Change in gastrointestinal symptom severity and quality of life (PAC-SYM and PAC-QOL scores) from baseline to 12 months, stratified by depth of muscular infiltration (1-6 mm, 7-12 mm, 13-20 mm)

    12 months

Secondary Outcomes (2)

  • Association Between Residual Bowel Wall Thickness and Surgical Complications

    12 months

  • Identification of Predictive Ultrasound Cut-off Values

    12 months

Eligibility Criteria

Age20 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of women of reproductive age diagnosed with deep infiltrating endometriosis involving the rectum or sigmoid colon, with muscularis propria infiltration between 1 and 20 mm as assessed by expert preoperative transvaginal ultrasound. Eligible patients are those scheduled to undergo laparoscopic rectal shaving as part of standard clinical care at a tertiary referral center for endometriosis. All participants provide written informed consent prior to enrollment.

You may qualify if:

  • Female patients aged 20-60 years
  • Rectal or sigmoid nodule with muscularis propria infiltration ≥1 mm and \<20 mm (assessed by expert transvaginal ultrasound)
  • Indication for surgery agreed upon with the patient
  • Written informed consent

You may not qualify if:

  • Previous major bowel surgery or primary indication for bowel resection
  • Inflammatory bowel disease, malignancy, or severe pelvic pathology
  • Inability to complete study questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Giorgia Gaia

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2026

First Posted

April 8, 2026

Study Start

April 7, 2026

Primary Completion (Estimated)

April 7, 2027

Study Completion (Estimated)

July 7, 2028

Last Updated

April 8, 2026

Record last verified: 2026-03